Velcura Therapeutics, Inc

Velcura Therapeutics™, Inc. is a leading biotechnology firm in the treatment of bone-related injuries and bone disorders. Velcura develops therapies directed at stimulating bone formation. Velcura can grow human bone outside the body (ex vivo) using a rapid (3 – 5 days) and reliable method. We apply molecular and biological bone assays to the systematic discovery of the genes, biological pathways, and drug candidates that accelerate bone formation. From this, we discover new therapies for bone disorders such as Osteoporosis, Bone Cancer, Bone Fractures, and other diseases of bone.

Contact Details: 4300 Varsity Dr., Suite D Ann Arbor Michigan 48108 United States of America Tel: 734-973-1000 Fax: 734-973-1001 Email: info@velcura.com WWW: www.velcura.com/

Loading...

Press Releases on Velcura Therapeutics, Inc:
Velcura Therapeutics, Inc. to Begin Clinical Trials in Rheumatoid Arthritis Patients	7th January, 2009	Velcura Therapeutics, Inc.	ANN ARBOR, Mich. Jan. 7 /PRNewswire/ -- Velcura Therapeutics Inc., a clinical-phase biotechnology company developing therapies for bone disease, has completed its second successful Investigational New
Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors	18th July, 2008	Velcura Therapeutics, Inc.	ANN ARBOR, Mich., July 18 /PRNewswire/ -- Velcura Therapeutics, Inc. CEO Michael Long, Ph.D., announced that William F. Brinkerhoff has joined the Board of Directors of the biotechnology company,

BioNews Results for Velcura Therapeutics, Inc:
Amicus Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 5:37AM Matching: therapeutics inc
Arana Therapeutics Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 5:14AM Matching: therapeutics inc
XTEN Data From Amunix and Versartis Featured in Nature Biotechnology as a Novel Platform for Increasing Serum Half-Life of Protein Therapeutics	Earthtimes.org:  Nov 15 2009 7:40PM Matching: therapeutics inc
BiomedReports: News and FDA Updates for PharmAthene (NYSE:PIP), Repros Therapeutics (Nasdaq:RPRX)	Quote.com Japan:  Nov 14 2009 10:27PM Matching: therapeutics inc
Maxygen, Inc. Commences Dutch Auction Tender Offer to Repurchase 6,557,377 Shares of Common Stock	KOTA Territory News:  Nov 14 2009 11:05PM Matching: therapeutics inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Velcura Therapeutics, Inc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 356 times since April 2007, the link to the organisation's website has been followed 70 times

Recent Search Terms used to find this page: Velcura Therapeutics Inc. | .

Search for more companies in Ann Arbor

Search for more companies in Michigan

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Velcura Therapeutics, Inc